Destra Insights

The world, in general, and healthcare investing continues to be a wild and crazy place. Of course, a good bit of this tumult derives from the Covid pandemic. The upcoming Presidential election has not contributed to settling things down either. There continue to be myriad opinions about the right path forward. We won’t articulate any particular view, but the fact is that we have to invest effectively for our shareholders in healthcare assets amidst a panoply of opinions and actions that have had a noticeable impact on sentiment and on the value of certain of the stocks which the Tekla Funds own.

At the moment, the healthcare sector is operating within an extremely complicated and volatile macroenvironment. The coronavirus epidemic came on very quickly and has changed the way that America and the world function. This impact may ultimately reverse but, at best, is here for some time.

There has been near-term volatility in Healthcare stemming from recent proposals, especially ahead of the 2020 Presidential election. Fundamentally, very little has changed in Healthcare.

CityWire recently interviewed Dr. Daniel R. Omstead, Ph.D., Chief Executive Officer of Tekla Capital Management LLC and President and Portfolio Manager of each of the Tekla Funds. This brief article provides some insights into the investment process at Tekla Capital Management as well as their outlook on the healthcare market today.